(Q39760224)

14 September 2017

1 reference

title

Treatment of acute leukaemia in children (English)

1 reference

14 September 2017

Treatment of acute leukeamia in children (English)

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

5 April 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

5 April 2023

author name string

A. M. Mauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A354831

5 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=354831

5 April 2023

publication date

1 June 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:S0308226178800046?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

https://api.elsevier.com/content/article/PII:S0308226178800046?httpAccept=text/plain

5 April 2023

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

5 April 2023

published in

Clinics in haematology

1 reference

14 September 2017

volume

7

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

245-258

1 reference

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Cessation of Therapy during Complete Remission of Childhood Acute Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Acute nonlymphocytic leukemia in 171 children

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Long-term results of reinforcement therapy in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Antisera to acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Prognostic significance of pretreatment proliferative activity in adult acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

The need for chemotherapy after prolonged complete remission in acute leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Interrupted vs. continued maintenance therapy in childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Active immunotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

The current status of the treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Acute myelogenous leukemia in children: a preliminary report of combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

The central nervous system in childhood leukemia.II. Subacute leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Factors that influence haematological remission duration in acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Combined modality therapy of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Early deaths in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin

1 reference

https://api.crossref.org/works/10.1016%2FS0308-2261%2878%2980004-6

7 January 2021

The immunosuppressive effects of long-term combination chemotherapy in children with acute leukemia in remission

6

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

Remission maintenance therapy in acute myelogenous leukemia

5 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris)

5 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia

5 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia

5 April 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0308-2261(78)80004-6

5 April 2023

Identifiers

0 references

1 reference